Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases

Allergology International

Volumn 64, Issue 1, 2015, Pages 27-34

  Miyata, Jun ^a   Arita, Makoto ^a,b  

^a Institute of Physical and Chemical Research   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Allergy; Asthma; Omega 3 fatty acid; Protectin; Specialized pro resolving mediator

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; MARESIN; OMEGA 3 FATTY ACID; PROTECTIN D1; RESOLVIN D1; RESOLVIN E1; UNCLASSIFIED DRUG; AUTACOID;

ADULTHOOD; ALLERGIC AIRWAY INFLAMMATION; ALLERGIC DISEASE; ASTHMA; CHILDHOOD; DIET SUPPLEMENTATION; DRUG SYNTHESIS; FISH; FOOD INTAKE; HUMAN; IN VIVO STUDY; INFANCY; LACTATION; NONHUMAN; OBSERVATIONAL STUDY; PREGNANCY; PRIORITY JOURNAL; REVIEW; ANIMAL; DISEASE MODEL; HYPERSENSITIVITY; IMMUNOLOGY; LIPID METABOLISM; METABOLISM; MOUSE;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; HUMANS; HYPERSENSITIVITY; INFLAMMATION MEDIATORS; LIPID METABOLISM; MICE;

EID: 84944160804     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.1016/j.alit.2014.08.003     Document Type: Review

References (112)

1. 1. Saravanan, P., Davidson, N.C., Schmidt, E.B., Calder, P.C., Cardiovascular effects of marine omega-3 fatty acids. Lancet 376 (2010), 540–550.
2. 2. Calder, P.C., Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. Br J Clin Pharmacol 75 (2013), 645–662.
3. 3. Yates, C.M., Calder, P.C., Ed Rainger, G., Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol Ther 141 (2014), 272–282.
4. 4. Kremmyda, L.S., Vlachava, M., Noakes, P.S., Diaper, N.D., Miles, E.A., Calder, P.C., Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review. Clin Rev Allergy Immunol 41 (2011), 36–66.
5. 5. Miles, E.A., Calder, P.C., Omega-6 and omega-3 polyunsaturated fatty acids and allergic diseases in infancy and childhood. Curr Pharm Des 20 (2014), 946–953.
6. 6. Laidlaw, T.M., Boyce, J.A., Cysteinyl leukotriene receptors, old and new; implications for asthma. Clin Exp Allergy 42 (2012), 1313–1320.
7. 7. Wenzel, S.E., Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy, 17, 1997 3S–12.
8. 8. Serhan, C.N., Chiang, N., Van Dyke, T.E., Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8 (2008), 349–361.
9. 9. Serhan, C.N., Savill, J., Resolution of inflammation: the beginning programs the end. Nat Immunol 6 (2005), 1191–1197.
10. 10. Braman, S.S., The global burden of asthma. Chest 130:1 Suppl. (2006), 4S–12.
11. 11. Bell, M.C., Busse, W.W., Severe asthma: an expanding and mounting clinical challenge. J Allergy Clin Immunol Pract 1 (2013), 110–121 quiz 22.
12. 12. Planaguma, A., Kazani, S., Marigowda, G., Haworth, O., Mariani, T.J., Israel, E., et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med 178 (2008), 574–582.
13. 13. Bhavsar, P.K., Levy, B.D., Hew, M.J., Pfeffer, M.A., Kazani, S., Israel, E., et al. Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma. Respir Res, 11, 2010, 71.
14. 14. Kazani, S., Planaguma, A., Ono, E., Bonini, M., Zahid, M., Marigowda, G., et al. Exhaled breath condensate eicosanoid levels associate with asthma and its severity. J Allergy Clin Immunol 132 (2013), 547–553.
15. 15. Fritscher, L.G., Post, M., Rodrigues, M.T., Silverman, F., Balter, M., Chapman, K.R., et al. Profile of eicosanoids in breath condensate in asthma and COPD. J Breath Res, 6, 2012, 026001.
16. 16. Levy, B.D., Bonnans, C., Silverman, E.S., Palmer, L.J., Marigowda, G., Israel, E., Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med 172 (2005), 824–830.
17. 17. Celik, G.E., Erkekol, F.O., Misirligil, Z., Melli, M., Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity. Clin Exp Allergy 37 (2007), 1494–1501.
18. 18. Wu, S.H., Yin, P.L., Zhang, Y.M., Tao, H.X., Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree. Pediatr Pulmonol 45 (2010), 333–340.
19. 19. Bonnans, C., Vachier, I., Chavis, C., Godard, P., Bousquet, J., Chanez, P., Lipoxins are potential endogenous antiinflammatory mediators in asthma. Am J Respir Crit Care Med 165 (2002), 1531–1535.
20. 20. Vachier, I., Bonnans, C., Chavis, C., Farce, M., Godard, P., Bousquet, J., et al. Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. J Allergy Clin Immunol 115 (2005), 55–60.
21. 21. Miyata, J., Fukunaga, K., Iwamoto, R., Isobe, Y., Niimi, K., Takamiya, R., et al. Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. J Allergy Clin Immunol 131 (2013), 353–360 e1-2.
22. 22. Freedman, S.D., Blanco, P.G., Zaman, M.M., Shea, J.C., Ollero, M., Hopper, I.K., et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 350 (2004), 560–569.
23. 23. Calvani, M., Alessandri, C., Sopo, S.M., Panetta, V., Pingitore, G., Tripodi, S., et al. Consumption of fish, butter and margarine during pregnancy and development of allergic sensitizations in the offspring: role of maternal atopy. Pediatr Allergy Immunol 17 (2006), 94–102.
24. 24. Romieu, I., Torrent, M., Garcia-Esteban, R., Ferrer, C., Ribas-Fito, N., Anto, J.M., et al. Maternal fish intake during pregnancy and atopy and asthma in infancy. Clin Exp Allergy 37 (2007), 518–525.
25. 25. Salam, M.T., Li, Y.F., Langholz, B., Gilliland, F.D., Maternal fish consumption during pregnancy and risk of early childhood asthma. J Asthma 42 (2005), 513–518.
26. 26. Sausenthaler, S., Koletzko, S., Schaaf, B., Lehmann, I., Borte, M., Herbarth, O., et al. Maternal diet during pregnancy in relation to eczema and allergic sensitization in the offspring at 2 y of age. Am J Clin Nutr 85 (2007), 530–537.
27. 27. Willers, S.M., Devereux, G., Craig, L.C., McNeill, G., Wijga, A.H., Abou El-Magd, W., et al. Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old children. Thorax 62 (2007), 773–779.
28. 28. Andreasyan, K., Ponsonby, A.L., Dwyer, T., Kemp, A., Dear, K., Cochrane, J., et al. A differing pattern of association between dietary fish and allergen-specific subgroups of atopy. Allergy 60 (2005), 671–677.
29. 29. Antova, T., Pattenden, S., Nikiforov, B., Leonardi, G.S., Boeva, B., Fletcher, T., et al. Nutrition and respiratory health in children in six Central and Eastern European countries. Thorax 58 (2003), 231–236.
30. 30. Chatzi, L., Torrent, M., Romieu, I., Garcia-Esteban, R., Ferrer, C., Vioque, J., et al. Diet, wheeze, and atopy in school children in Menorca, Spain. Pediatr Allergy Immunol 18 (2007), 480–485.
31. 31. Dunder, T., Kuikka, L., Turtinen, J., Rasanen, L., Uhari, M., Diet, serum fatty acids, and atopic diseases in childhood. Allergy 56 (2001), 425–428.
32. 32. Hodge, L., Salome, C.M., Peat, J.K., Haby, M.M., Xuan, W., Woolcock, A.J., Consumption of oily fish and childhood asthma risk. Med J Aust 164 (1996), 137–140.
33. 33. Huang, S.L., Lin, K.C., Pan, W.H., Dietary factors associated with physician-diagnosed asthma and allergic rhinitis in teenagers: analyses of the first Nutrition and Health Survey in Taiwan. Clin Exp Allergy 31 (2001), 259–264.
34. 34. Kim, J.L., Elfman, L., Mi, Y., Johansson, M., Smedje, G., Norback, D., Current asthma and respiratory symptoms among pupils in relation to dietary factors and allergens in the school environment. Indoor Air 15 (2005), 170–182.
35. 35. Kull, I., Bergstrom, A., Lilja, G., Pershagen, G., Wickman, M., Fish consumption during the first year of life and development of allergic diseases during childhood. Allergy 61 (2006), 1009–1015.
36. 36. Nafstad, P., Nystad, W., Magnus, P., Jaakkola, J.J., Asthma and allergic rhinitis at 4 years of age in relation to fish consumption in infancy. J Asthma 40 (2003), 343–348.
37. 37. Hoppu, U., Rinne, M., Lampi, A.M., Isolauri, E., Breast milk fatty acid composition is associated with development of atopic dermatitis in the infant. J Pediatr Gastroenterol Nutr 41 (2005), 335–338.
38. 38. Barros, R., Moreira, A., Fonseca, J., Delgado, L., Castel-Branco, M.G., Haahtela, T., et al. Dietary intake of alpha-linolenic acid and low ratio of n-6:n-3 PUFA are associated with decreased exhaled NO and improved asthma control. Br J Nutr 106 (2011), 441–450.
39. 39. Broadfield, E.C., McKeever, T.M., Whitehurst, A., Lewis, S.A., Lawson, N., Britton, J., et al. A case-control study of dietary and erythrocyte membrane fatty acids in asthma. Clin Exp Allergy 34 (2004), 1232–1236.
40. 40. Burns, J.S., Dockery, D.W., Neas, L.M., Schwartz, J., Coull, B.A., Raizenne, M., et al. Low dietary nutrient intakes and respiratory health in adolescents. Chest 132 (2007), 238–245.
41. 41. Kitz, R., Rose, M.A., Schubert, R., Beermann, C., Kaufmann, A., Bohles, H.J., et al. Omega-3 polyunsaturated fatty acids and bronchial inflammation in grass pollen allergy after allergen challenge. Respir Med 104 (2010), 1793–1798.
42. 42. Kompauer, I., Demmelmair, H., Koletzko, B., Bolte, G., Linseisen, J., Heinrich, J., Association of fatty acids in serum phospholipids with lung function and bronchial hyperresponsiveness in adults. Eur J Epidemiol 23 (2008), 175–190.
43. 43. Li, J., Xun, P., Zamora, D., Sood, A., Liu, K., Daviglus, M., et al. Intakes of long-chain omega-3 (n-3) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study. Am J Clin Nutr 97 (2013), 173–178.
44. 44. McKeever, T.M., Lewis, S.A., Cassano, P.A., Ocke, M., Burney, P., Britton, J., et al. The relation between dietary intake of individual fatty acids, FEV1 and respiratory disease in Dutch adults. Thorax 63 (2008), 208–214.
45. 45. Woods, R.K., Raven, J.M., Walters, E.H., Abramson, M.J., Thien, F.C., Fatty acid levels and risk of asthma in young adults. Thorax 59 (2004), 105–110.
46. 46. Barden, A.E., Mori, T.A., Dunstan, J.A., Taylor, A.L., Thornton, C.A., Croft, K.D., et al. Fish oil supplementation in pregnancy lowers F2-isoprostanes in neonates at high risk of atopy. Free Radic Res 38 (2004), 233–239.
47. 47. Dunstan, J.A., Mitoulas, L.R., Dixon, G., Doherty, D.A., Hartmann, P.E., Simmer, K., et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatr Res 62 (2007), 689–694.
48. 48. Dunstan, J.A., Mori, T.A., Barden, A., Beilin, L.J., Holt, P.G., Calder, P.C., et al. Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur J Clin Nutr 58 (2004), 429–437.
49. 49. Dunstan, J.A., Roper, J., Mitoulas, L., Hartmann, P.E., Simmer, K., Prescott, S.L., The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clin Exp Allergy 34 (2004), 1237–1242.
50. 50. Krauss-Etschmann, S., Shadid, R., Campoy, C., Hoster, E., Demmelmair, H., Jimenez, M., et al. Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am J Clin Nutr 85 (2007), 1392–1400.
51. 51. Warstedt, K., Furuhjelm, C., Duchen, K., Falth-Magnusson, K., Fageras, M., The effects of omega-3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatr Res 66 (2009), 212–217.
52. 52. Denburg, J.A., Hatfield, H.M., Cyr, M.M., Hayes, L., Holt, P.G., Sehmi, R., et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatr Res 57 (2005), 276–281.
53. 53. Dunstan, J.A., Mori, T.A., Barden, A., Beilin, L.J., Taylor, A.L., Holt, P.G., et al. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J Allergy Clin Immunol 112 (2003), 1178–1184.
54. 54. Dunstan, J.A., Mori, T.A., Barden, A., Beilin, L.J., Taylor, A.L., Holt, P.G., et al. Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin Exp Allergy 33 (2003), 442–448.
55. 55. Krauss-Etschmann, S., Hartl, D., Rzehak, P., Heinrich, J., Shadid, R., Del Carmen Ramirez-Tortosa, M., et al. Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women. J Allergy Clin Immunol 121 (2008), 464–470 e6.
56. 56. Lauritzen, L., Kjaer, T.M., Fruekilde, M.B., Michaelsen, K.F., Frokiaer, H., Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2-year-old children. Lipids 40 (2005), 669–676.
57. 57. Prescott, S.L., Barden, A.E., Mori, T.A., Dunstan, J.A., Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord-blood-derived neutrophils. Clin Sci (Lond) 113 (2007), 409–416.
58. 58. Furuhjelm, C., Warstedt, K., Larsson, J., Fredriksson, M., Bottcher, M.F., Falth-Magnusson, K., et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatr 98 (2009), 1461–1467.
59. 59. Olsen, S.F., Osterdal, M.L., Salvig, J.D., Mortensen, L.M., Rytter, D., Secher, N.J., et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomized controlled trial. Am J Clin Nutr 88 (2008), 167–175.
60. 60. Almqvist, C., Garden, F., Xuan, W., Mihrshahi, S., Leeder, S.R., Oddy, W., et al. Omega-3 and omega-6 fatty acid exposure from early life does not affect atopy and asthma at age 5 years. J Allergy Clin Immunol 119 (2007), 1438–1444.
61. 61. Hodge, L., Salome, C.M., Hughes, J.M., Liu-Brennan, D., Rimmer, J., Allman, M., et al. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J 11 (1998), 361–365.
62. 62. Marks, G.B., Mihrshahi, S., Kemp, A.S., Tovey, E.R., Webb, K., Almqvist, C., et al. Prevention of asthma during the first 5 years of life: a randomized controlled trial. J Allergy Clin Immunol 118 (2006), 53–61.
63. 63. Mihrshahi, S., Peat, J.K., Marks, G.B., Mellis, C.M., Tovey, E.R., Webb, K., et al. Eighteen-month outcomes of house dust mite avoidance and dietary fatty acid modification in the Childhood Asthma Prevention Study (CAPS). J Allergy Clin Immunol 111 (2003), 162–168.
64. 64. Peat, J.K., Mihrshahi, S., Kemp, A.S., Marks, G.B., Tovey, E.R., Webb, K., et al. Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study. J Allergy Clin Immunol 114 (2004), 807–813.
65. 65. Damsgaard, C.T., Lauritzen, L., Kjaer, T.M., Holm, P.M., Fruekilde, M.B., Michaelsen, K.F., et al. Fish oil supplementation modulates immune function in healthy infants. J Nutr 137 (2007), 1031–1036.
66. 66. Vaisman, N., Zaruk, Y., Shirazi, I., Kaysar, N., Barak, V., The effect of fish oil supplementation on cytokine production in children. Eur Cytokine Netw 16 (2005), 194–198.
67. 67. Mihrshahi, S., Peat, J.K., Webb, K., Oddy, W., Marks, G.B., Mellis, C.M., Effect of omega-3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age. Pediatr Allergy Immunol 15 (2004), 517–522.
68. 68. Nagakura, T., Matsuda, S., Shichijyo, K., Sugimoto, H., Hata, K., Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 16 (2000), 861–865.
69. 69. Emelyanov, A., Fedoseev, G., Krasnoschekova, O., Abulimity, A., Trendeleva, T., Barnes, P.J., Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J 20 (2002), 596–600.
70. 70. Mickleborough, T.D., Lindley, M.R., Ionescu, A.A., Fly, A.D., Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest 129 (2006), 39–49.
71. 71. Mickleborough, T.D., Murray, R.L., Ionescu, A.A., Lindley, M.R., Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 168 (2003), 1181–1189.
72. 72. Schubert, R., Kitz, R., Beermann, C., Rose, M.A., Lieb, A., Sommerer, P.C., et al. Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge. Int Arch Allergy Immunol 148 (2009), 321–329.
73. 73. Bilal, S., Haworth, O., Wu, L., Weylandt, K.H., Levy, B.D., Kang, J.X., Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses. Biochim Biophys Acta 1812 (2011), 1164–1169.
74. 74. Morin, C., Fortin, S., Cantin, A.M., Rousseau, E., Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma. Am J Respir Cell Mol Biol 45 (2011), 366–375.
75. 75. Morin, C., Fortin, S., Cantin, A.M., Rousseau, E., MAG-EPA resolves lung inflammation in an allergic model of asthma. Clin Exp Allergy 43 (2013), 1071–1082.
76. 76. Yokoyama, A., Hamazaki, T., Ohshita, A., Kohno, N., Sakai, K., Zhao, G.D., et al. Effect of aerosolized docosahexaenoic acid in a mouse model of atopic asthma. Int Arch Allergy Immunol 123 (2000), 327–332.
77. 77. Schuster, G.U., Bratt, J.M., Jiang, X., Pedersen, T.L., Grapov, D., Adkins, Y., et al. Dietary long-chain omega-3 fatty acids do not diminish eosinophilic pulmonary inflammation in mice. Am J Respir Cell Mol Biol 50 (2014), 626–636.
78. 78. Yin, H., Liu, W., Goleniewska, K., Porter, N.A., Morrow, J.D., Peebles, R.S. Jr., Dietary supplementation of omega-3 fatty acid-containing fish oil suppresses F2-isoprostanes but enhances inflammatory cytokine response in a mouse model of ovalbumin-induced allergic lung inflammation. Free Radic Biol Med 47 (2009), 622–628.
79. 79. Buckley, C.D., Gilroy, D.W., Serhan, C.N., Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 40 (2014), 315–327.
80. 80. Yamada, T., Tani, Y., Nakanishi, H., Taguchi, R., Arita, M., Arai, H., Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice. FASEB J 25 (2011), 561–568.
81. 81. Isobe, Y., Arita, M., Iwamoto, R., Urabe, D., Todoroki, H., Masuda, K., et al. Stereochemical assignment and anti-inflammatory properties of the omega-3 lipid mediator resolvin E3. J Biochem 153 (2013), 355–360.
82. 82. Isobe, Y., Arita, M., Matsueda, S., Iwamoto, R., Fujihara, T., Nakanishi, H., et al. Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid. J Biol Chem 287 (2012), 10525–10534.
83. 83. Kubota, T., Arita, M., Isobe, Y., Iwamoto, R., Goto, T., Yoshioka, T., et al. Eicosapentaenoic acid is converted via omega-3 epoxygenation to the anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid. FASEB J 28 (2014), 586–593.
84. 84. Chiang, N., Serhan, C.N., Dahlen, S.E., Drazen, J.M., Hay, D.W., Rovati, G.E., et al. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev 58 (2006), 463–487.
85. 85. Marcheselli, V.L., Mukherjee, P.K., Arita, M., Hong, S., Antony, R., Sheets, K., et al. Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostagl Leukot Essent Fat Acids 82 (2010), 27–34.
86. 86. Park, C.K., Lu, N., Xu, Z.Z., Liu, T., Serhan, C.N., Ji, R.R., Resolving TRPV1- and TNF-alpha-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J Neurosci 31 (2011), 15072–15085.
87. 87. Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C.H., Yang, R., et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A 107 (2010), 1660–1665.
88. 88. Chiang, N., Fredman, G., Backhed, F., Oh, S.F., Vickery, T., Schmidt, B.A., et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484 (2012), 524–528.
89. 89. Dalli, J., Winkler, J.W., Colas, R.A., Arnardottir, H., Cheng, C.Y., Chiang, N., et al. Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem Biol 20 (2013), 188–201.
90. 90. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201 (2005), 713–722.
91. 91. Arita, M., Ohira, T., Sun, Y.P., Elangovan, S., Chiang, N., Serhan, C.N., Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 178 (2007), 3912–3917.
92. 92. Ohira, T., Arita, M., Omori, K., Recchiuti, A., Van Dyke, T.E., Serhan, C.N., Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J Biol Chem 285 (2010), 3451–3461.
93. 93. Schwab, J.M., Chiang, N., Arita, M., Serhan, C.N., Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447 (2007), 869–874.
94. 94. Levy, B.D., Kohli, P., Gotlinger, K., Haworth, O., Hong, S., Kazani, S., et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol 178 (2007), 496–502.
95. 95. Camateros, P., Tamaoka, M., Hassan, M., Marino, R., Moisan, J., Marion, D., et al. Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463. Am J Respir Crit Care Med 175 (2007), 1241–1249.
96. 96. Grela, F., Aumeunier, A., Bardel, E., Van, L.P., Bourgeois, E., Vanoirbeek, J., et al. The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma. J Immunol 186 (2011), 284–290.
97. 97. Xirakia, C., Koltsida, O., Stavropoulos, A., Thanassopoulou, A., Aidinis, V., Sideras, P., et al. Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. Am J Respir Crit Care Med 181 (2010), 1207–1216.
98. 98. Koltsida, O., Karamnov, S., Pyrillou, K., Vickery, T., Chairakaki, A.D., Tamvakopoulos, C., et al. Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation. EMBO Mol Med 5 (2013), 762–775.
99. 99. Levy, B.D., Resolvin D1 and resolvin E1 promote the resolution of allergic airway inflammation via shared and distinct olecular counter-regulatory pathways. Front Immunol, 3, 2012, 390.
100. 100. Rogerio, A.P., Haworth, O., Croze, R., Oh, S.F., Uddin, M., Carlo, T., et al. Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J Immunol 189 (2012), 1983–1991.
101. 101. Aoki, H., Hisada, T., Ishizuka, T., Utsugi, M., Kawata, T., Shimizu, Y., et al. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun 367 (2008), 509–515.
102. 102. Aoki, H., Hisada, T., Ishizuka, T., Utsugi, M., Ono, A., Koga, Y., et al. Protective effect of resolvin E1 on the development of asthmatic airway inflammation. Biochem Biophys Res Commun 400 (2010), 128–133.
103. 103. Haworth, O., Cernadas, M., Levy, B.D., NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation. J Immunol 186 (2011), 6129–6135.
104. 104. Haworth, O., Cernadas, M., Yang, R., Serhan, C.N., Levy, B.D., Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol 9 (2008), 873–879.
105. 105. Barnig, C., Cernadas, M., Dutile, S., Liu, X., Perrella, M.A., Kazani, S., et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med, 5, 2013, 174ra26.
106. 106. Doyle, J.R., Krishnaji, S.T., Zhu, G., Xu, Z.Z., Heller, D., Ji, R.R., et al. Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic pain. J Biol Chem 289 (2014), 13385–13396.
107. 107. Levy, B.D., De Sanctis, G.T., Devchand, P.R., Kim, E., Ackerman, K., Schmidt, B.A., et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med 8 (2002), 1018–1023.
108. 108. Levy, B.D., Lukacs, N.W., Berlin, A.A., Schmidt, B., Guilford, W.J., Serhan, C.N., et al. Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. FASEB J 21 (2007), 3877–3884.
109. 109. Sanak, M., Levy, B.D., Clish, C.B., Chiang, N., Gronert, K., Mastalerz, L., et al. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J 16 (2000), 44–49.
110. 110. Yamaguchi, H., Higashi, N., Mita, H., Ono, E., Komase, Y., Nakagawa, T., et al. Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma. Clin Exp Allergy 41 (2011), 1711–1718.
111. 111. Hasan, R.A., O'Brien, E., Mancuso, P., Lipoxin A(4) and 8-isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus. Pediatr Crit Care Med 13 (2012), 141–145.
112. 112. Tahan, F., Saraymen, R., Gumus, H., The role of lipoxin A4 in exercise-induced bronchoconstriction in asthma. J Asthma 45 (2008), 161–164.